This IDC Survey is the first in the series of IDC Health Insights reports that examine European life sciences organizations' digital transformation (DX) strategies, priorities, and trends for 2020 across the five key dimensions of DX: leadership and culture, operations, patients and customers, intelligence and insights, and work model transformation.
This report focuses on the “leadership and culture” dimension, analyzing the data collected from the life science sample of IDC's European Tech and Pulse Industry Survey 2019–2020. IDC's European Tech and Industry Pulse Survey is a landmark study of IT solutions, investment priorities, and emerging technologies. This year, the survey covered over 75% of the European economy, including Russia, Poland, and the Czech Republic. The life science sample consisted of 137 respondents across 13 European countries. Where applicable, the results are presented by sub-region (Western Europe and Central and Eastern Europe) and the three life-sciences sub-verticals (pharmaceuticals, medical devices, and clinical research and development).
Digitally determined leadership implies addressing digital transformation with an execution strategy that allows for synergies not only across the enterprise, but also beyond. "In the face of the COVID-19 crisis, it is now even more imperative that European life sciences companies ensure the alignment of digital innovation strategies with vital business priorities, such as operational efficiency, and make their digital roadmaps more 'context-aware,' adapting to the broader ecosystem-wide vision and dynamics to ensure due resiliency and drive innovation and business performance" — Senior Research Analyst Nino Giguashvili, IDC Health Insights Europe.